Last 12 months
Inside the activity.
3 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 23, 2022 21:01 UTC | GrantCommon Stock | 40,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-005230 · ownership.xml · nonDerivative · entry 2 Paranjape Manish · CIK 0001912833 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,813 F2 · security: Represents long-term incentive restricted stock units. Each long-term incentive restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The long-term incentive restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Transaction Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Transaction Date. F6 · security: The vesting and delivery of the shares of common stock underlying the reported securities are subject to the receipt of shareholder approval approving an increase in the authorized shares under the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| February 22, 2022 Filed Feb 23, 2022 21:01 UTC | GrantCommon Stock | 45,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-005230 · ownership.xml · nonDerivative · entry 1 Paranjape Manish · CIK 0001912833 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,767 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest as follows: (i) one-fifth on February 22, 2023 and (ii) the remaining in 48 equal (monthly) increments, with each vesting tranche being subject to continued employment on such applicable vesting date. F6 · security: The vesting and delivery of the shares of common stock underlying the reported securities are subject to the receipt of shareholder approval approving an increase in the authorized shares under the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| January 02, 2022 Filed Jan 4, 2022 21:08 UTC | GrantCommon Stock | 55,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 4 Prevoznik Michael Edward JR · CIK 0001898290 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,224 F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| January 02, 2022 Filed Jan 4, 2022 21:08 UTC | GrantCommon Stock | 55,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 3 Prevoznik Michael Edward JR · CIK 0001898290 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,668 F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| January 02, 2022 Filed Jan 4, 2022 21:08 UTC | GrantCommon Stock | 55,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 2 Prevoznik Michael Edward JR · CIK 0001898290 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,112 F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary of the Grant Date, and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| January 02, 2022 Filed Jan 4, 2022 21:08 UTC | GrantCommon Stock | 55,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000363 · ownership.xml · nonDerivative · entry 1 Prevoznik Michael Edward JR · CIK 0001898290 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,556 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. Once the market capitalization target has been met, 20% of the restricted stock units will vest on the one-year anniversary from January 2, 2022 (the "Grant Date"), and the remaining 80% of the restricted stock units will vest monthly over the four years following the one year anniversary of the Grant Date. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
|
| January 02, 2022 Filed Jan 5, 2022 02:09 UTC |
Garrity DavidDirector
|
GrantCommon Stock | 31,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000369 · ownership.xml · nonDerivative · entry 1 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,638 F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:14 UTC |
Handerhan MichalDirector · COO · 10% owner
|
GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 5 Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,608,497 F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:14 UTC |
Handerhan MichalDirector · COO · 10% owner
|
GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 4 Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,497,386 F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:14 UTC |
Handerhan MichalDirector · COO · 10% owner
|
GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 3 Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,386,275 F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:14 UTC |
Handerhan MichalDirector · COO · 10% owner
|
GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 2 Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,275,164 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:14 UTC |
Handerhan MichalDirector · COO · 10% owner
|
GrantCommon Stock | 111,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000379 · ownership.xml · nonDerivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · COO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164,053 Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:12 UTC |
Allen Charles WDirector · CEO · 10% owner
|
GrantCommon Stock | 173,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 5 Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,022,874 F4 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $400,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:12 UTC |
Allen Charles WDirector · CEO · 10% owner
|
GrantCommon Stock | 173,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 4 Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,849,263 F3 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $200,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:12 UTC |
Allen Charles WDirector · CEO · 10% owner
|
GrantCommon Stock | 173,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 3 Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,675,652 F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $150,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:12 UTC |
Allen Charles WDirector · CEO · 10% owner
|
GrantCommon Stock | 173,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 2 Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,502,041 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the Issuer's market capitalization reaches and sustains a market capitalization for 30 consecutive days above $100,000,000. F5 · security: The vesting of the reported securities are subject to shareholder approval approving an increase in the 2021 Equity Incentive Plan or the creation of a new plan as required under Nasdaq rules. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:12 UTC |
Allen Charles WDirector · CEO · 10% owner
|
GrantCommon Stock | 173,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000374 · ownership.xml · nonDerivative · entry 1 Allen Charles W · CIK 0001599502 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,328,430 Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:10 UTC |
Lee Charles BenjaminDirector
|
GrantCommon Stock | 31,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000372 · ownership.xml · nonDerivative · entry 1 Lee Charles Benjamin · CIK 0001751744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,348 F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter. Read SEC document |
| January 02, 2022 Filed Jan 5, 2022 02:10 UTC |
Van Cleef Carol RDirector
|
GrantCommon Stock | 31,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000371 · ownership.xml · nonDerivative · entry 1 Van Cleef Carol R · CIK 0001856584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,444 F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest in four equal installments at the end of each calendar quarter. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Garrity DavidDirector
|
ConversionSeries C-2 Convertible Preferred Stock · Derivative | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022685 · ownership.xml · derivative · entry 2 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · price: Not applicable. F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Garrity DavidDirector
|
ConversionCommon Stock | 54,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022685 · ownership.xml · nonDerivative · entry 1 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Handerhan MichalDirector · Chief Operating Officer · 10% owner
|
ConversionSeries C-2 Convertible Preferred Stock · Derivative | 275,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022684 · ownership.xml · derivative · entry 2 Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,002,942 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · price: Not applicable. F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Handerhan MichalDirector · Chief Operating Officer · 10% owner
|
ConversionCommon Stock | 1,002,942 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022684 · ownership.xml · nonDerivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Allen Charles WDirector · Chief Executive Officer · 10% owner
|
ConversionSeries C-2 Convertible Preferred Stock · Derivative | 810,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022683 · ownership.xml · derivative · entry 2 Allen Charles W · CIK 0001599502 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,954,118 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · price: Not applicable. F1 · derivative.exercise_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · derivative.expiration_date: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · derivative.underlying_shares: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 20:05 UTC |
Allen Charles WDirector · Chief Executive Officer · 10% owner
|
ConversionCommon Stock | 2,954,118 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-022683 · ownership.xml · nonDerivative · entry 1 Allen Charles W · CIK 0001599502 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,154,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F1 · price: The Series C-2 Preferred Stock (the "C-2") automatically converted into the issuer's common stock upon the issuer listing its Common Stock on The Nasdaq Stock Market, LLC. The conversion price was $1.70 per share, adjusted for the reverse stock split described in footnote (2) below. As previously disclosed, the C-2 would automatically convert into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · balance_after: Reflects a 1-for-10 reverse stock split which became effective in August 2021, prior to the filing date of this Form 4. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 16:03 UTC |
Lee AndrewChief Financial Officer
|
GrantCommon Stock | 507,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-015713 · ownership.xml · nonDerivative · entry 1 Lee Andrew · CIK 0001870177 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,813 F1 · security: Represents restricted stock units ("RSUs"). Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest over a five-year period as follows: (i) 20% of the RSUs (101,563) will vest on the one-year anniversary of the Transaction Date and (ii) the remaining 80% of the RSUs (406,250) will vest monthly over the following four years, with each applicable incremental vesting amount being subject to the reporting person's continued service as the Chief Financial Officer of the issuer. Read SEC document |
| April 22, 2021 Filed Apr 23, 2021 16:22 UTC |
Allen Charles WDirector · CEO, CFO
|
PurchaseCommon Stock | 7,009 | $5,700.00 | $39,951,300.00 |
DisclosureSEC source: 0001493152-21-009521 · ownership.xml · nonDerivative · entry 1 Allen Charles W · CIK 0001599502 · Director · CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007,009 F1 · security: The Reporting Person purchased the shares in a private transaction - not on the open market. Two million of the reported shares represented unvested restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 12, 2021 20:05 UTC |
Lee Charles BenjaminDirector
|
GrantStock Options (Right to Buy) · Derivative | 175,000 | Not disclosed Strike: $1.03 | Not disclosed |
DisclosureSEC source: 0001493152-21-008539 · ownership.xml · derivative · entry 2 Lee Charles Benjamin · CIK 0001751744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2026-04-01 F2 · security: The stock options shall vest as follow: 70,000 options will vest on April 1, 2022 and the remaining options will vest based upon the following milestones involving the issuer's stock price: 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.288; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.609; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.012; and 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.515. F3 · price: Not applicable. Read SEC document |
| April 01, 2021 Filed Apr 12, 2021 20:05 UTC |
Lee Charles BenjaminDirector
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008539 · ownership.xml · nonDerivative · entry 1 Lee Charles Benjamin · CIK 0001751744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on a national securities exchange. Read SEC document |
| April 01, 2021 Filed Apr 13, 2021 20:05 UTC |
Van Cleef Carol RDirector
|
GrantStock Options (Right to Buy) · Derivative | 175,000 | Not disclosed Strike: $1.03 | Not disclosed |
DisclosureSEC source: 0001493152-21-008648 · ownership.xml · derivative · entry 2 Van Cleef Carol R · CIK 0001856584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2026-04-01 F2 · security: The stock options shall vest as follow: 70,000 options will vest on April 1, 2022 and the remaining options will vest based upon the following milestones involving the issuer's stock price: 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.288; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $1.609; 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.012; and 26,250 options when the trailing 20-day average closing stock price is greater than or equal to $2.515. F3 · price: Not applicable. Read SEC document |
| April 01, 2021 Filed Apr 13, 2021 20:05 UTC |
Van Cleef Carol RDirector
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-008648 · ownership.xml · nonDerivative · entry 1 Van Cleef Carol R · CIK 0001856584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,958 F1 · shares: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on a national securities exchange. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:36 UTC |
Allen Charles WDirector · CEO, CFO
|
GrantStock Options (Right to Buy) · Derivative | 7,500,000 | Not disclosed Strike: $0.19 | Not disclosed |
DisclosureSEC source: 0001493152-21-000223 · ownership.xml · derivative · entry 3 Allen Charles W · CIK 0001599502 · Director · CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500,000 Underlying: Common Stock · 7,500,000 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F5 · security: Not applicable. F5 · price: Not applicable. F4 · derivative.exercise_date: The stock options shall vest as follow: 3 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. F4 · derivative.expiration_date: The stock options shall vest as follow: 3 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:36 UTC |
Allen Charles WDirector · CEO, CFO
|
GrantSeries C-2 Convertible Preferred Stock · Derivative | 810,000 | $810,000.00 Strike: $0.17 | $656,100,000,000.00 |
DisclosureSEC source: 0001493152-21-000223 · ownership.xml · derivative · entry 2 Allen Charles W · CIK 0001599502 · Director · CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,764,706 Underlying: Common Stock · 4,764,706 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:36 UTC |
Allen Charles WDirector · CEO, CFO
|
GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-000223 · ownership.xml · nonDerivative · entry 1 Allen Charles W · CIK 0001599502 · Director · CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE. F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:31 UTC |
Handerhan MichalDirector · COO
|
GrantStock Options (Right to Buy) · Derivative | 3,500,000 | Not disclosed Strike: $0.19 | Not disclosed |
DisclosureSEC source: 0001493152-21-000216 · ownership.xml · derivative · entry 3 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500,000 Underlying: Common Stock · 3,500,000 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F5 · security: Not applicable. F5 · price: Not applicable. F4 · derivative.exercise_date: The stock options shall vest as follow: 1.4 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. F4 · derivative.expiration_date: The stock options shall vest as follow: 1.4 million options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:31 UTC |
Handerhan MichalDirector · COO
|
GrantSeries C-2 Convertible Preferred Stock · Derivative | 275,000 | $810,000.00 Strike: $0.17 | $222,750,000,000.00 |
DisclosureSEC source: 0001493152-21-000216 · ownership.xml · derivative · entry 2 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,617,647 Underlying: Common Stock · 1,617,647 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:31 UTC |
Handerhan MichalDirector · COO
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-000216 · ownership.xml · nonDerivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE. F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:33 UTC |
Garrity DavidDirector
|
GrantStock Options (Right to Buy) · Derivative | 1,000,000 | Not disclosed Strike: $0.19 | Not disclosed |
DisclosureSEC source: 0001493152-21-000220 · ownership.xml · derivative · entry 3 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F5 · security: Not applicable. F5 · price: Not applicable. F4 · derivative.exercise_date: The stock options shall vest as follow: 400 thousand options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. F4 · derivative.expiration_date: The stock options shall vest as follow: 400 thousand options will vest on January 1, 2022 and the remaining options will vest based upon certain performance milestones involving the issuer's stock price. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:33 UTC |
Garrity DavidDirector
|
GrantSeries C-2 Convertible Preferred Stock · Derivative | 15,000 | $15,000.00 Strike: $0.17 | $225,000,000.00 |
DisclosureSEC source: 0001493152-21-000220 · ownership.xml · derivative · entry 2 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires not disclosed F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F3 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F3 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 21:33 UTC |
Garrity DavidDirector
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-000220 · ownership.xml · nonDerivative · entry 1 Garrity David · CIK 0001720019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,835 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units shall vest when the issuer lists its Common Stock on the Nasdaq or NYSE. F2 · security: The vesting (and exercisability for the stock options) of the reported securities are subject to shareholder approval. Additionally, the Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. Read SEC document |
| January 01, 2021 Filed Jan 20, 2021 19:48 UTC Amendment |
Handerhan MichalDirector · COO
|
GrantSeries C-2 Convertible Preferred Stock · Derivative | 275,000 | $275,000.00 Strike: $0.17 | $75,625,000,000.00 |
DisclosureSEC source: 0001493152-21-001419 · ownership.xml · derivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,617,647 Underlying: Common Stock · 1,617,647 shares Expires not disclosed F1 · security: The Series C-2 Convertible Preferred Stock (the "Series C-2") is subject to redemption at 107% of investment value if shareholder approval is not received. F3 · price: The price of the securities in the original Form 4 was erroneously disclosed as $810,000. This Form 4/A amends the original to Form 4 to correct this error. F2 · derivative.exercise_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. F2 · derivative.expiration_date: Each share of Series C-2 is convertible into shares of the issuer's common stock beginning on the two-year anniversary of the initial issuance date at a per-share conversion rate determined by dividing the stated value ($1.00 per share as of the initial issuance date) by $0.17, subject to anti-dilution adjustment provisions. Further, the Series C-2 automatically converts into shares of common stock upon the earlier of: (i) the four-year anniversary of the initial issuance date, and (ii) the issuer's common stock being listed on a national securities exchange. Read SEC document |
| February 08, 2019 Filed Feb 9, 2019 02:30 UTC |
Handerhan MichalDirector · Chief Operating Officer
|
SaleCommon Stock | 2,437,627 | $0.01 | $29,251.52 |
DisclosureSEC source: 0001493152-19-001636 · ownership.xml · nonDerivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 22:00 UTC |
Allen Charles WDirector · CEO, CFO
|
SaleCommon Stock | 1,857,829 | $0.02 | $37,156.58 |
DisclosureSEC source: 0001493152-18-017388 · ownership.xml · nonDerivative · entry 1 Allen Charles W · CIK 0001599502 · Director · CEO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Exercise / conversionWarrants · Derivative | 1,556 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · derivative · entry 6 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,556 shares Expires 2020-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Exercise / conversionWarrants · Derivative | 2,084 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · derivative · entry 5 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,084 shares Expires 2020-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Tax withholdingCommon Stock | 663 | $0.08 | $49.73 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 4 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,437,627 Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Exercise / conversionCommon Stock | 1,556 | $0.03 | $49.79 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 3 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,438,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Tax withholdingCommon Stock | 695 | $0.08 | $52.13 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 2 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,436,734 Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:51 UTC |
Handerhan MichalDirector · COO
|
Exercise / conversionCommon Stock | 2,084 | $0.03 | $52.10 |
DisclosureSEC source: 0001493152-17-008236 · form4.xml · nonDerivative · entry 1 Handerhan Michal · CIK 0001599522 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,437,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 17:49 UTC |
Allen Charles WDirector · CEO,CFO
|
Exercise / conversionWarrants · Derivative | 1,556 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001493152-17-008235 · form4.xml · derivative · entry 6 Allen Charles W · CIK 0001599502 · Director · CEO,CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,556 shares Expires 2020-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.